跳至主要内容
临床试验/NCT01717261
NCT01717261已完成1 期

Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast Cancer

Maisonneuve-Rosemont Hospital2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
2
主要终点
Acute toxicity

研究概览

简要总结

The purpose of this study is to determine if partial breast irradiation administered in a single preoperative fraction is tolerable.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female aged 60 years or older.
  • Invasive ductal carcinoma.
  • Unifocal disease.
  • Tumors less than 2cm.
  • No clinical evidence of nodal disease.
  • Estrogen receptor status (ER) positive.
  • Her2 negative.

排除标准

  • Age less than 60 years.
  • BRCA 1 and/or BRCA 2 mutation.
  • Tumour histology limited to lobular carcinoma only.
  • Neoadjuvant hormonal manipulation or chemotherapy.
  • More than one primary tumour in different quadrants of the same breast.
  • Inability to view tumor on imaging.

结局指标

主要结局

Acute toxicity

时间窗: 6 months

Assess acute toxicity and wound healing complications from the preoperative radiation treatment as per NCI CTCAE Common Toxicity Scale.

次要结局

  • Chronic toxicity(2 years)
  • Cosmetic outcome(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Yassa

Radiation Oncologist

Maisonneuve-Rosemont Hospital

研究点 (2)

Loading locations...

相似试验

Single Pre-Operative Radiation Therapy (SPORT) for... | 临床试验